お知らせ

Nishihara M, Suzuki M, Asatani S, Nagasawa Y, Tsukamoto M, Akiya K, Kobayashi H, Kitamura N, Nakamura H

A Case of Anti-neutrophil Cytoplasmic Antibody-negative Eosinophilic Granulomatosis with Polyangiitis Complicated with Peripheral Neuropathy that Underwent Remission Induction with Mepolizumab Monotherapy.

Intern Med (IF1.271)

Masataka Kuwana, Tomoki Ito, Shugo Kowata, Yoshihiro Hatta, Katsumichi 

Fujimaki, Kensuke Naito, Shingo Kurahashi, Toshiya Kagoo, Kazuki Tanimoto, 

So Saotome, Yoshiaki Tomiyama,

Fostamatinib for the treatment of Japanese patients with primary immune thrombocytopenia: A phase 3, placebo-controlled, double-blind, parallel-group study

British Jounal of Hematology

Shun-ichi Kimura , Hiroaki Shimizu, Takuya Miyazaki, Masatoshi Sakurai, Susumu Tanoue, Kensuke Kayamori, Chikako Ohwada, Kazuki Yoshimura, Hideki Nakasone, Takuma Ohashi, Katsuhiro Shono, Takayoshi Tachibana, Kaoru Hatano, Keigo Okada, Yuta Kimura, Sachiko Seo, Noriko Doki, Masatsugu Tanaka, Yoshihiro Hatta, Satoshi Takahashi, Yoshinobu Kanda 

1. Impact of standard-dose dipeptidyl peptidase-4 inhibitors on the incidence of graft-versus-host disease after allogeneic hematopoietic cell transplantation

2. Bone Marrow Transplantation

Nakamura H and Takei M

Special Issue ‘Viral Infection and Autoimmune Diseases’

Viruses (IF5.818)

Iriyama N, Miura K, Takahashi H, Nakagawa M, Iizuka K, Hamada T, Koike T, Kurihara K, Endo T, Nakayama T, Hatta Y, Nakamura H

Clinical entity of cytomegalovirus disease in patients with malignant lymphoma on bendamustine therapy: a single-institution experience.

Leukemia and Lymphoma(IF2.996)

中村英樹　日本臨牀　特集シェーグレン症候群　ー診断・治療の最新動向ー（単著）　p1654-1660、2022年10月、日本臨牀社

Iizuka K, Morishita S, Nishizaki Y, Iizuka Y, Iriyama N, Ochiai T, Yanagisawa N, Yasuda H, Ando J, Gotoh A, Takei M, Hatta Y,  Nakamura H, Nakayama T, Komatsu N

Von Willebrand factor activity levels are influenced by driver mutation status in polycythemia vera and essential thrombocythemia patients with well-controlled platelet counts